Tag: Cancer: Prostate
Overtreatment of Prostate Cancer Increasing in Men With Short Life Expectancy
From 2000 to 2019, definitive treatment for those with intermediate- or high-risk disease and limited life expectancy increased
Long-Term Complications After Prostate Cancer Treatment Not Uncommon
12-year risk for urinary or sexual complications 7.23 and 2.76 times higher for prostatectomy, radiotherapy versus no treatment
AI Aids Risk Prediction Classification for Prostate Cancer
Authors say this classification has the potential to minimize overtreatment and undertreatment
Certain Pesticides Tied to Increased Prostate Cancer Incidence, Mortality
Twenty-two pesticides showed direct associations with prostate cancer incidence in discovery and replication cohorts
Higher Heathy Eating Index Score Beneficial in Prostate Cancer
Higher Healthy Eating Index score linked to significantly lower risk for grade reclassification in men undergoing active surveillance
Stereotactic Body Radiotherapy Viable Alternative for Localized Prostate Cancer
Findings show equivalent efficacy to moderately fractionated radiotherapy with enhanced convenience
Time to Testosterone Recovery Varies With ADT Duration
Nonlinear association seen for effective castration period with metastasis-free survival for any ADT duration
ASTRO: Intensity-Modulated RT, Proton Beam Therapy Have Similar Outcomes in Prostate Cancer
No differences seen for quality of life and tumor control with localized prostate cancer
No Infections Seen After Transperineal Biopsy for Prostate Cancer
Similar cancer detection rates seen for transperineal versus transrectal biopsy, but reduction in infections seen for transperineal
Omitting Biopsy With Negative MRI Reduces Detection of Clinically Insignificant Prostate Cancer
More than half of diagnoses of clinically insignificant prostate cancer eliminated by omitting biopsy in men with negative MRI
